| __timestamp | Verona Pharma plc | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4101058 | 581800000 |
| Thursday, January 1, 2015 | 10763215 | 671900000 |
| Friday, January 1, 2016 | 5579049 | 876700000 |
| Sunday, January 1, 2017 | 32051299 | 857900000 |
| Monday, January 1, 2018 | 24482286 | 822200000 |
| Tuesday, January 1, 2019 | 43892589 | 778200000 |
| Wednesday, January 1, 2020 | 44505000 | 512600000 |
| Friday, January 1, 2021 | 79406000 | 681000000 |
| Saturday, January 1, 2022 | 49283000 | 662200000 |
| Sunday, January 1, 2023 | 17282730 | 910700000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, innovation is key. Viatris Inc. and Verona Pharma plc, two prominent players, have shown distinct approaches to research and development (R&D) over the past decade. From 2014 to 2023, Viatris consistently outpaced Verona Pharma in R&D spending, investing nearly 25 times more on average. In 2023, Viatris allocated a staggering 910 million dollars, marking a 56% increase from its 2014 expenditure. Meanwhile, Verona Pharma's investment peaked in 2021 at approximately 79 million dollars, a significant rise from its 2014 figure, but still a fraction of Viatris's commitment. This disparity highlights Viatris's aggressive strategy to lead in pharmaceutical innovation, while Verona Pharma adopts a more conservative approach. As the industry evolves, these investment patterns may shape the future landscape of drug development and market leadership.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.